Product Title: Biodentine™: Properties and Clinical Applications (Original PDF from Publisher)
Format:
Publisher PDF, File Size = 9.40 MB
Overview (Details, Topics and Speakers):
By Imad About
This book is a comprehensive guide to BiodentineTM, an innovative biocompatible and bioactive material based on pure tricalcium silicate that can permanently replace dentin and can also serve as a temporary enamel substitute. Although BiodentineTM has been widely used across the world for the past decade, this is the first book to be devoted to its properties, interactions with the soft and hard tissues, and its multiple clinical applications. The coverage encompasses applications in primary and permanent teeth, in specialties as diverse as restorative dentistry, endodontics, paediatric dentistry, dental traumatology, and prosthetic dentistry. BiodentineTM application both in vital pulp therapy and endodontic procedures is illustrated and clinical step by step protocols are provided. The book provides a detailed update on BiodentineTM use to preserve the pulp vitality in direct/indirect pulp capping, pulpotomy and irreversible pulpitis treatment. It also details BiodentineTM use for non-vital teeth treatment in indications such as root/furcation perforation repair, apexification as well as in regenerative endodontic procedures.
BiodentineTM: Properties and Clinical Applications will be a rich source of guidance and information for all dentists as well as dental students and academics.
Product Details
- Publisher : Springer; 1st ed. 2022 edition (October 21, 2021)
- Language : English
- Hardcover : 235 pages
- ISBN-10 : 3030809315
- ISBN-13 : 978-3030809317
- ISBN-13 : 9783030809317
- eText ISBN: 9783030809324
Delivery Method
the Biodentine™: Properties and Clinical Applications (Original PDF from Publisher) course/book will be provided for customer as download link. download link has NO Expiry and can be used anytime.
Contact Us
contact us to our email at support@med-cme.com or fill in the form below:
Reviews
There are no reviews yet.